Favipiravir: all 54 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHFRecruitingNCT06860334Phase 2
• Assessing Antiviral Treatments in Early Symptomatic RSVRecruitingNCT06488300Phase 2
• ISTH/ANRS 0409s INTEGRATE Lassa Fever StudyRecruitingNCT06212336Phase 2/3
• Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy VolunteersRecruitingNCT06024421Phase 1
• A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingNCT05648448Phase 2
• Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)RecruitingNCT05041907Phase 2
• AGILE (Early Phase Platform Trial for COVID-19)RecruitingNCT04746183Phase 1/2
• Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 PatientsCompletedNCT05502081Phase 4Results posted
• The Prevent Severe COVID-19 (PRESECO) StudyCompletedNCT04600895Phase 3Results posted
• Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19CompletedNCT04542694Phase 3Results posted
• Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19CompletedNCT04532931Phase 2Results posted
• Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 PatientsTerminatedNCT04529499Phase 3Results posted
• Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting ConditionsCompletedNCT04406194Phase 1Results posted
• Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting ConditionsCompletedNCT04400682Phase 1Results posted
• Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19CompletedNCT04358549Phase 2Results posted
• Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19CompletedNCT04346628Phase 2Results posted
• Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated InfluenzaCompletedNCT01068912Phase 2Results posted
• Clinical Trial For Early SARS-CoV-2 (COVID-19) TreatmentCompletedNCT04981379Phase 3
• Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa FeverCompletedNCT04907682Phase 2
• Favipiravir in High-risk COVID-19 PatientsCompletedNCT04818320Phase 3
• Investigation the Effect of Montelukast in COVID-19Status unknownNCT04718285Phase 2
• Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting ConditionsStatus unknownNCT04651959Phase 1
• Clinical Trial of Favipiravir Treatment of Patients With COVID-19CompletedNCT04600999Phase 3
• The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19Status unknownNCT04558463Phase 3
• Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19CompletedNCT04501783Phase 3
• FLARE: Favipiravir +/- Lopinavir: A RCT of Early AntiviralsCompletedNCT04499677Phase 2
• Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries , Egypt) Versus Avigan 200 mg Tablets (Man. by Toyama Chemical Co., Ltd Japan)CompletedNCT04478448Phase 1
• Favipiravir Therapy in Adults With Mild COVID-19CompletedNCT04464408Phase 2/3
• Control of COVID-19 Outbreaks in Long Term CareTerminatedNCT04448119Phase 2
• An Adaptive Clinical Trial of Antivirals for COVID-19 InfectionStatus unknownNCT04445467Phase 2
• Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting ConditionsCompletedNCT04444986Phase 1
• An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19Status unknownNCT04434248Phase 2/3
• A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19Status unknownNCT04425460Phase 3
• Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19Status unknownNCT04411433Phase 3
• Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting ConditionsCompletedNCT04407000Phase 1
• Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of BangladeshStatus unknownNCT04402203Phase 2/3
• FAvipiravir and HydroxyChloroquine Combination TherapyCompletedNCT04392973Not applicable
• Favipiravir vs Hydroxychloroquine vs Control in COVID -19CompletedNCT04387760Phase 2
• Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19CompletedNCT04376814Not applicable
• Early Intervention in COVID-19: Favipiravir Verses Standard CareCompletedNCT04373733Phase 3
• Favipiravir in Hospitalized COVID-19 PatientsStatus unknownNCT04359615Phase 4
• Efficacy of Faviprevir in COVID-19 TreatmentCompletedNCT04351295Phase 2/3
• Efficacy and Safety of Favipiravir in Management of COVID-19CompletedNCT04349241Phase 3
• Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19Status unknownNCT04336904Phase 3
• Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to PositiveStatus unknownNCT04333589Not applicable
• Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus PneumoniaStatus unknownNCT04319900Phase 2/3
• A Pharmacokinetics Study of Favipiravir in Patients With Severe InfluenzaCompletedNCT03394209Phase 2
• Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the SemenTerminatedNCT02739477Phase 2
• Efficacy of Favipiravir Against Severe Ebola Virus DiseaseCompletedNCT02662855Phase 2
• Efficacy of Favipiravir Against Ebola (JIKI)CompletedNCT02329054Phase 2
• Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316CompletedNCT02026349Phase 3
• Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in AdultsCompletedNCT02008344Phase 3
• T-705a Multicenter Study in Adults Subjects With Uncomplicated InfluenzaCompletedNCT01728753Phase 1/2
• Pharmacokinetics of Favipiravir in Volunteers With Hepatic ImpairmentCompletedNCT01419457Phase 1

← Favipiravir overview